4//SEC Filing
Wegman Mark N 4
Accession 0001062993-19-002344
CIK 0000875622other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 5:47 PM ET
Size
6.4 KB
Accession
0001062993-19-002344
Insider Transaction Report
Form 4
Wegman Mark N
Director
Transactions
- Exercise/Conversion
Common Stock, $0.001 par value
2019-05-15$20.95/sh+15,000$314,250→ 80,272 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-15−15,000→ 0 totalExercise: $20.95Exp: 2019-06-24→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The option vested monthly with respect to 1/12 of the total number of shares from the date of grant (6/25/2009).
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001405235
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 5:47 PM ET
- Size
- 6.4 KB